Omentin as a novel biomarker of metabolic risk factors. - Wikidata - awgldk - TriplyDB

Omentin as a novel biomarker of metabolic risk factors.

Omentin as a novel biomarker of metabolic risk factors.

http://www.wikidata.org/entity/Q36138940

about

Sex dimorphism and depot differences in adipose tissue function A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis Effect of Body Mass Index on Posttonsillectomy Hemorrhage Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease Association of circulating C1q/TNF-related protein 1 levels with coronary artery disease in men.Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.The effect of enteral nutrition on adipokines in patients with acute pancreatitis.Novel adipokines and bone metabolism.Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis.Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease.Serum levels of omentin-1 are increased after weight loss and are particularly associated with increases in obese children with metabolic syndrome.Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients.Adipose Tissue-Derived Omentin-1 Function and Regulation.Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice.Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease.Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet.Population-based serum omentin-1 levels: paradoxical association with cardiometabolic disorders primarily in men.Counteractive effects of omentin-1 against atherogenesis†.Serum Omentin-1 in Psoriasis.

P2860

Q26999869-31149256-8B86-468F-8156-0423E8249ADF Q30384899-03FB8743-A236-4918-B29A-F671F8482050 Q33572695-35B7AACE-4FD6-4787-B611-343B96510EBB Q33710451-46DCB700-A373-4E5C-ABC0-F6996EA225E6 Q34079744-6FF14640-9D2E-49EA-A0AA-7DFCF1AB4431 Q35190964-631ADB8E-EFD3-4A13-9732-8F2E70B78951 Q36163654-FDA2DDE4-1330-4C8D-AE70-2192617CB2B7 Q36177659-64CC3E4B-3DD2-4AB1-8D44-B520EFC51618 Q36619316-1EE99FAA-FC1E-47E6-BEF6-B1082C9ACF57 Q36951691-2F0B0DC2-6420-4124-8643-A0B524EF72ED Q37045241-74884DE6-7087-46DB-9F10-64F4960FCAA5 Q37514552-8A6EFD97-3418-429E-8FE5-0C92685EA365 Q38612064-9B9153E9-2D2C-42AB-8D26-84854FD5E93E Q38810169-1D2C932C-9BC0-4BA2-A09E-44DF5B65A989 Q39390964-BA99D31A-69D3-4581-A7EA-348B0CBC7564 Q40161032-FAA68E71-8167-4265-ADC1-3D7C64D1226D Q46074545-109510B4-B451-4547-9EB7-CC07A2BCA79F Q47096054-F9B929B8-90B8-4936-8269-A628013CC215 Q50072128-6F18764F-F571-4D5D-A812-D9E1264BB44E Q53800814-FFC9D437-E7DD-46AC-99FD-4A7A40416A9E Q55252634-4EF09AA8-8CCB-4BDF-B5BE-21AA926388EE

P2860

Omentin as a novel biomarker of metabolic risk factors.

http://www.wikidata.org/entity/Q36138940

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Omentin as a novel biomarker of metabolic risk factors.

@ast

Omentin as a novel biomarker of metabolic risk factors.

@en

type

label

Omentin as a novel biomarker of metabolic risk factors.

@ast

Omentin as a novel biomarker of metabolic risk factors.

@en

prefLabel

Omentin as a novel biomarker of metabolic risk factors.

@ast

Omentin as a novel biomarker of metabolic risk factors.

@en

P1433

Q36138940-C39C5F4A-B20D-45F4-B939-045CF0C2411B

P1476

Q36138940-CCA21122-3C47-4564-94C8-DC7AFD02527E

P2093

Q36138940-2DEB662B-5619-4B00-B206-A78933170E37

Q36138940-3C97E007-6A5A-437A-BBDD-9433AD91BD44

Q36138940-43CD3F14-8CA0-4349-9347-61AF0D347256

Q36138940-4DE203DE-6686-4685-A73E-0F79C72C70B9

Q36138940-585A9DBC-9E21-421C-B978-30D36366F57C

Q36138940-5B4E4354-25C1-4554-A389-9BD5AF28C075

Q36138940-772A6DF1-9824-4F08-A45F-A4ED950629CD

Q36138940-92AC2623-4DCF-4D83-8FD0-C38AA222D151

Q36138940-CB07FE88-8898-4019-8A53-FEFB495BBDAF

Q36138940-F1EB382C-B9C1-4095-A104-EF2A7174AD38

P2860

Q36138940-2014347A-1D27-4B5B-859E-E2DCE40AE608

Q36138940-3D59BCB3-D69D-474E-A0AB-CAA3EC008D9A

Q36138940-698FCDCC-2CEC-4C7B-95F2-8D442355CE3B

Q36138940-715380D9-FB87-4873-8AB5-83D90CE09F97

Q36138940-72E0B79E-18EC-4F74-B0BB-D99226BC82ED

Q36138940-81BFA2B8-F2B2-4391-931C-E04543AF8695

Q36138940-89DFE578-A55A-40F2-85A2-7EA5AC43B654

Q36138940-99B8335E-44C9-4466-A883-031F3C1F9945

Q36138940-A1032642-DF83-476B-ACAD-A89F785A843D

Q36138940-A4465762-77BA-496C-98D8-0DEA439DC605

P2888

Q36138940-9D91CB84-23F3-448B-8E45-35A3FD661210

P304

Q36138940-C1CC72ED-BDE3-44FF-9BD8-F0AC430F7051

P31

Q36138940-AE7366B9-06E7-4E16-93BD-F3BAEC2AD323

P356

Q36138940-D86159C2-D041-4822-8FE8-C400853ACDF8

P433

Q36138940-65660E16-CD24-4F50-82A0-8589A999A0E8

P478

Q36138940-0327719F-E8A7-40C3-838C-5B18AF5C99A1

P577

Q36138940-FC8C7911-6E29-4441-B9C7-6F67A58F03CB

P5875

Q36138940-8B0977B6-243C-437C-BF48-B46C2BC01B91

P6179

Q36138940-A0267115-451E-40F8-B90E-6C003BDE7704

P698

Q36138940-EBF5B386-7596-46B9-B0D8-601FAABE5120

P921

Q36138940-F458C2A4-6D5F-4BDC-B461-6C9DB2BD96D0

P932

Q36138940-F938BF5E-9264-4085-8802-EF34B03E96FD

P356

P1433

Diabetology and Metabolic Syndrome

P1476

Omentin as a novel biomarker of metabolic risk factors.

@en

P2093

Akiko Higuchi

http://www.w3.org/2001/XMLSchema#string

Hiroko Terasaki

http://www.w3.org/2001/XMLSchema#string

Koji Ohashi

http://www.w3.org/2001/XMLSchema#string

Nobuo Ikeda

http://www.w3.org/2001/XMLSchema#string

Noriyuki Ouchi

http://www.w3.org/2001/XMLSchema#string

Rei Shibata

http://www.w3.org/2001/XMLSchema#string

Ryotaro Takahashi

http://www.w3.org/2001/XMLSchema#string

Shinji Kihara

http://www.w3.org/2001/XMLSchema#string

Toyoaki Murohara

http://www.w3.org/2001/XMLSchema#string

Yuya Terakura

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

Adipokines in inflammation and metabolic disease

Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall.

Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue.

Obesity, adiponectin and vascular inflammatory disease.

Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.

Abdominal obesity and metabolic syndrome.

Adipokines, myokines and cardiovascular disease.

Adiponectin and cardiovascular disease.

Association of serum omentin-1 levels with coronary artery disease.

P2888

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1758-5996-4-37

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230572002

http://www.w3.org/2001/XMLSchema#string

P6179

1038290107

http://www.w3.org/2001/XMLSchema#string

P698

22835063

http://www.w3.org/2001/XMLSchema#string

P921

P932

3411496

http://www.w3.org/2001/XMLSchema#string